No products in the cart.
No benefit of erlotinib in combined hepatocellular carcinoma treatment
1. In a phase III trial of over 700 patients with hepatocellular carcinoma (HCC), there was no significant difference in ...
Tag: hepatocellular carcinoma
2 Minute Medicine Rewind June 30 – July 7, 2014
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Effect of ...
No survival benefit with everolimus treatment for hepatocellular carcinoma [EVOLVE-1 Trial]
1. Compared to placebo, treatment with everolimus did not improve survival in patients with advanced hepatocellular carcinoma (HCC) who had ...
Low-strength evidence for hepatocellular carcinoma screening in liver disease
1. This systematic review identified very-low strength evidence pertaining to the benefits of screening for hepatocellular carcinoma (HCC) among patients ...
Chemoembolization comparable to standard-of-care for small hepatocellular cancers
1. Transarterial chemoembolization (TACE) was shown to have survival and treatment response rates comparable to both hepatic resection (HR) and ...
Tumor size, chemoembolization response may predict hepatocellular carcinoma recurrence
Image: PD 1. In patients with hepatocellular carcinoma who underwent liver transplantation, response to transarterial chemoembolization and radiologic size of ...
High hepatitis B antigen predicts hepatic cancer recurrence
Image: PD 1. The risk of hepatocellular carcinoma recurrence increased with high levels of hepatitis B surface antigen (HBsAg), specifically ...
Hepatocellular carcinoma screening reduces mortality [Classics Series]
Image: PD 1. Patients at high risk for hepatocellular carcinoma who underwent biannual screening with serum AFP levels and liver ...
Hep B reactivation common after liver resection for HBV-related hepatocellular carcinoma
Image: PD 1. Liver failure was more frequent in post-hepatectomy patients with HBV reactivation, resulting in shorter 3-year disease-free survival ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.